Francesca Catella-Lawson
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 8
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 2
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 6
-
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Acute Myocardial Infarction Research 2
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects 8
-
- Heparin-Induced Thrombocytopenia and Thrombosis 2
-
- Synthesis of β-Lactam Compounds 2
-
- Autoimmune Bullous Skin Diseases 2
- Co-authors
- Garret A. FitzGeraldShiv KapoorBrendan McAdamJohn A. LawsonIssam A. MardiniBarbara TournierMuredach P. ReillyAndrew J. Cucchiara
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Circulation (2 papers)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Francesca Catella-Lawson
15 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Pharmacology 2.1k
- Biochemistry 716
- Internal Medicine 292
- Cardiology and Cardiovascular Medicine 1.3k
- Pharmacology 283
Countries citing papers authored by Francesca Catella-Lawson
This map shows the geographic impact of Francesca Catella-Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Catella-Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Catella-Lawson more than expected).
Fields of papers citing papers by Francesca Catella-Lawson
This network shows the impact of papers produced by Francesca Catella-Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Catella-Lawson. The network helps show where Francesca Catella-Lawson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francesca Catella-Lawson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 4 | |
| 2 | 2001 | 114 | |
| 3 | 2001 | 58 | |
| 4 | 2001 | 47 | |
| 5 | Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirinbreakdown → | 2001 | 1008 |
| 6 | 2000 | 122 | |
| 7 | THROMBOSIS IN PATIENTS WITH CONNECTIVE TISSUE DISEASES TREATED WITH SPECIFIC CYCLOOXYGENASE 2 INHIBITORS | 2000 | 27 |
| 8 | 1999 | 2 | |
| 9 | 1999 | 478 | |
| 10 | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2breakdown → | 1999 | 1040 |
| 11 | 1998 | 110 | |
| 12 | 1997 | 12 | |
| 13 | 1997 | 7 | |
| 14 | 1996 | 14 | |
| 15 | 1995 | 10 |
About Francesca Catella-Lawson
Francesca Catella-Lawson is a scholar working on Internal Medicine, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 3.1k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Inflammatory mediators and NSAID effects (8 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Synthesis of β-Lactam Compounds (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Acute Myocardial Infarction Research (2 papers). The work is most often cited by research in Pharmacology (2.1k citations), Biochemistry (716 citations) and Internal Medicine (292 citations). Francesca Catella-Lawson has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Garret A. FitzGerald, Shiv Kapoor, Brendan McAdam, John A. Lawson, Issam A. Mardini, Barbara Tournier, Muredach P. Reilly, Andrew J. Cucchiara, Sachin Vyas and Leslie J. Crofford. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.